Glaxo Wellcome earmarks more for research

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

Black scholar at UCL claims that he lost out on a permanent job after his proposed course ‘scared’ the academy

  • David Parkins illustration (28 May 2015)

Is there a way for the two tribes to rub along? An academic and an administrator consider the rules of engagement

  • James Fryer illustration (28 May 2015)

A process at the heart of science is based on faith rather than evidence, says Richard Smith, and vested interests keep it in place

London centre that hosts Moodle environment affected

Diana Beech explains why her choice at the ballot box was an act of defiance against other academics